CN103432397B - Traditional Chinese medicine effective part composition for treating thromboangiitis obliterans - Google Patents

Traditional Chinese medicine effective part composition for treating thromboangiitis obliterans Download PDF

Info

Publication number
CN103432397B
CN103432397B CN201310358200.XA CN201310358200A CN103432397B CN 103432397 B CN103432397 B CN 103432397B CN 201310358200 A CN201310358200 A CN 201310358200A CN 103432397 B CN103432397 B CN 103432397B
Authority
CN
China
Prior art keywords
chinese medicine
thromboangiitis obliterans
part composition
traditional chinese
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310358200.XA
Other languages
Chinese (zh)
Other versions
CN103432397A (en
Inventor
张群
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhang Qun
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310358200.XA priority Critical patent/CN103432397B/en
Publication of CN103432397A publication Critical patent/CN103432397A/en
Application granted granted Critical
Publication of CN103432397B publication Critical patent/CN103432397B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine effective part composition for treating thromboangiitis obliterans. The traditional Chinese medicine effective part composition comprises the following raw materials according to certain parts by weight: perilla frutescens, bletilla striata, trametes versicolor, Chinese photinia leaves, lance asiabell root and beautyberry leaf. The traditional Chinese medicine effective part composition has the effects of warming channel to remove coldness, promoting blood circulation to remove meridian obstruction, promoting the circulation of qi to disperse blood stasis, clearing heat to promote diuresis, detoxicating to relieve pain, tonifying Qi and nourishing blood, and has obvious curative effects, no negative side effect and high security in treatment of thromboangiitis obliterans.

Description

A kind of Chinese medicinal effective-part composition for the treatment of thromboangiitis obliterans
Technical field
The present invention relates to Chinese medicine composition field, be specifically related to a kind of Chinese medicinal effective-part composition being used for the treatment of thromboangiitis obliterans.
Background technology
Thromboangiitis obliterans, has another name called spontaneous gangrene, is a kind of more common chronic progressive external angiopathy.Clinical main manifestations is skin color and the temperature change of sick lower limb vein, intermittent claudication, stationary pain, and severe patient can complicated by ulcer, gangrene, the most easily suffers from male adults.Modern Western medicine there is no unified understanding so far to vasculitic pathogeny, it is generally acknowledged how closely related with sympathetic nerve function disorder and autoimmune response etc.The risk factor that smoking room is generally acknowledged at present both at home and abroad.In addition, cold, humidity, infection, wound etc. can become potential inducement.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicinal effective-part composition for the preparation for the treatment of thromboangiitis obliterans, this active component composition can treat thromboangiitis obliterans, and not easily recurs.
Above-mentioned purpose of the present invention is achieved by the following technical programs:
The primary disease cause of disease and diseases caused by exogenous pathogenic factor cold-damp, eating and drinking without temperance, seven emotions cross pole or sexual strain, and prolonged illness deficiency in origin etc. are relevant.The current traditional Chinese medical science is summarized as yang-energy weakness, cold blood stasis, turbid damp pents up, the venation that is hampered, the hepatic and renal YIN deficiency, excessive noxious heat, asthenia of qi and blood lose, channels stasis blocking.
Treat a Chinese medicinal effective-part composition for thromboangiitis obliterans, be made up of the following raw material according to mass fraction meter: Fructus Perillae Frutescentis 26, the Pseudobulbus Bletillae (Rhizoma Bletillae) 21, Coriolous Dersicolor (Fr.) Quel 20, Folium Photiniae (Folium Photiniae serrulatae) 16, Radix Codonopsis Lanceolatae 14 and Folium Callicarpae Formosanae 3.
The preparation method of Chinese medicinal effective-part composition of the present invention is that add 16 times of water gagings, boil with high heat, change slow fire boiling into 2 hours, waste, to obtain final product by above-mentioned raw materials compositions according to proportioning combination drying.
Compared with prior art, the present invention has following beneficial effect:
Find through experiment, the Chinese medicinal effective-part composition made according to proportioning of the present invention has the effect of dispelling cold by warming the meridian, promoting blood circulation to remove obstruction in the collateral, regulating qi to disperse stagnation, clearing away heat-damp and promoting diuresis, removing toxic substances pain relieving, benefiting qi and nourishing blood, may be used for treating thromboangiitis obliterans, not easily recur after healing.
Detailed description of the invention
Explain the present invention further below in conjunction with embodiment, but embodiment does not limit in any form to the present invention.
embodiment 1
Fructus Perillae Frutescentis 26g, Pseudobulbus Bletillae (Rhizoma Bletillae) 21g, Coriolous Dersicolor (Fr.) Quel 20g, Folium Photiniae (Folium Photiniae serrulatae) 16g, Radix Codonopsis Lanceolatae 14g and Folium Callicarpae Formosanae 3g, add 16 times of water gagings after drying, after boiling with intense fire, then use slow fire decocting 120min, gained decoction is for subsequent use.
embodiment 2
Clinical observation Patients With Thromboangitis Obliterans 200.Patient is all diagnosed as thromboangiitis obliterans through clinical diagnosis.Embodiment 1 gained decoction is taken, 2 times on the 1st to patient, sooner or later bfore meals, continuous 30 days.
The patient census taking embodiment 1 gained decoction the results are shown in Table 1.Effective in table 1 comprises cures and effectively, wherein, cure and refer to that cardinal symptom disappears, wound heals completely, and suffering limb disturbance of blood circulation is alleviated or obviously improved, and resumes work in 1 year without recurring; Effectively refer to that clinical symptoms major part disappears or significantly alleviates, rest pain disappears, and skin temperature and color and luster are clearly better, wound healing or close to healing, blood circulation is slight obstacle, can work.Invalid refer to through treatment, clinical symptoms and sign all without improve, even increase the weight of.
Table 1
Number of cases Effective Invalid Obvious effective rate (%)
200 187 13 93.5
Known by above-mentioned data, after decoction made by Chinese medicine of the present invention, can in 30 days the treatment thromboangiitis obliterans of highly significant.
embodiment 3
Use the decoction administration ICR mice that embodiment 1 is obtained, body weight 20 ~ 25g, male and female half and half, successive administration 60d.
Through prerun, the decoction toxicity that embodiment 1 obtains is very low, does not measure LD50, therefore carries out maximum dosage-feeding mensuration on the one to mice.Maximum dosage-feeding is 400ml/d, observes none example and be poisoned to death after 60 days, and all healthy survival, proves that the decoction that compositions of the present invention is made can not toxic side effect to human body thus.

Claims (2)

1. treat a Chinese medicine composition for thromboangiitis obliterans, it is characterized in that being made up of the following raw material according to mass fraction meter: Fructus Perillae Frutescentis 26, the Pseudobulbus Bletillae (Rhizoma Bletillae) 21, Coriolous Dersicolor (Fr.) Quel 20, Folium Photiniae (Folium Photiniae serrulatae) 16, Radix Codonopsis Lanceolatae 14 and Folium Callicarpae Formosanae 3.
2. the Chinese medicine composition for the treatment of thromboangiitis obliterans according to claim 1, is characterized in that described Chinese medicine composition makes decoction.
3. treat the preparation method of the Chinese medicine composition of thromboangiitis obliterans described in claim 1 or 2, it is characterized in that add 16 times of water gagings, boil with high heat, change slow fire boiling into 2 hours, waste, to obtain final product by each crude drug according to proportioning combination drying.
4. the application of Chinese medicine composition described in claim 1 or 2, is characterized in that the medicine of described Chinese medicine composition for the preparation for the treatment of thromboangiitis obliterans.
CN201310358200.XA 2013-08-17 2013-08-17 Traditional Chinese medicine effective part composition for treating thromboangiitis obliterans Expired - Fee Related CN103432397B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310358200.XA CN103432397B (en) 2013-08-17 2013-08-17 Traditional Chinese medicine effective part composition for treating thromboangiitis obliterans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310358200.XA CN103432397B (en) 2013-08-17 2013-08-17 Traditional Chinese medicine effective part composition for treating thromboangiitis obliterans

Publications (2)

Publication Number Publication Date
CN103432397A CN103432397A (en) 2013-12-11
CN103432397B true CN103432397B (en) 2015-04-15

Family

ID=49686181

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310358200.XA Expired - Fee Related CN103432397B (en) 2013-08-17 2013-08-17 Traditional Chinese medicine effective part composition for treating thromboangiitis obliterans

Country Status (1)

Country Link
CN (1) CN103432397B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1245715A (en) * 1999-08-04 2000-03-01 章学常 Yankang powder (paste) for relieving inflammation
CN1772229A (en) * 2005-10-20 2006-05-17 叶明伟 Chinese herbal medicine decoction for treating virulent heat-evil type thrombotic angeitis and its prepn

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1245715A (en) * 1999-08-04 2000-03-01 章学常 Yankang powder (paste) for relieving inflammation
CN1772229A (en) * 2005-10-20 2006-05-17 叶明伟 Chinese herbal medicine decoction for treating virulent heat-evil type thrombotic angeitis and its prepn

Also Published As

Publication number Publication date
CN103432397A (en) 2013-12-11

Similar Documents

Publication Publication Date Title
CN103405698A (en) Traditional Chinese medicine liniment for treating acnes and preparation method thereof
CN102327586A (en) Medicament for treating chilblain and preparation method thereof
CN104225450A (en) Traditional Chinese medicine for treating depression
CN103536850B (en) A kind of Chinese medicine of internal and external application treatment verruca plana
CN105412426A (en) Traditional Chinese medicine for lowering blood pressure
CN104689132A (en) Traditional Chinese medicine composition for treating psoriasis
CN103432397B (en) Traditional Chinese medicine effective part composition for treating thromboangiitis obliterans
CN103638485A (en) Chinese medicinal composition for treating dyspepsia of hepatopathy patients
CN103432333B (en) Composition consisting of effective traditional Chinese medicine parts and used for treating hypothyroidism
CN103494900A (en) Traditional Chinese medicine for treating stiff neck
CN105311460A (en) Traditional Chinese medicine for treating vascular neuralgia headache
CN103494941B (en) Traditional Chinese medicine composite for treating pharyngitis and preparation method thereof and application thereof
CN104056231B (en) A kind of Chinese medicine composition of cooperation western medical treatment senile skin pruritus
CN103768312A (en) Traditional Chinese medicine effective part composition for treating Meniere's disease
CN103585534A (en) Traditional Chinese medicine effective part composition for treating erythema multiforme
CN106389721A (en) Traditional Chinese medicine lotion for removing dandruff and preparation method of traditional Chinese medicine lotion
CN103768341A (en) Traditional Chinese medicine effective part composition for treating primary glaucoma
CN105288436A (en) Medicament for treatment of chronic eczema
CN105168448A (en) Compound burn cream and preparation method thereof
CN105663904A (en) Traditional Chinese medicine composition for treating peripheral neuritis
CN104435979B (en) A kind of medicine for treating rheumatic lumbocrural pain pain
CN104689254A (en) Traditional Chinese medicine composition for treating psoriasis
CN103550592A (en) Traditional Chinese medicinal effective part composition for treating priapism
CN105287758A (en) Traditional Chinese medicine for treating urticaria
CN103989786B (en) A kind of Chinese medicine for the treatment of pruritus vulvae

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: ZHANG QUN

Free format text: FORMER OWNER: GUANGZHOU YUNQIAO BIOTECHNOLOGY CO., LTD.

Effective date: 20150226

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20150226

Address after: The Eastern Development Zone of Guangzhou City, Guangdong province 510000 two Building Room 302 Xinyuan Street Chunhui

Applicant after: Zhang Qun

Address before: 510000, Guangzhou, Guangdong, Luogang District Province, No. 6, No. 601, Lai Lai Road

Applicant before: Guangzhou Yunqiao Biological Technology Co., Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150415

Termination date: 20150817

EXPY Termination of patent right or utility model